The Oscars red carpet reignites the Hollywood thinness debate

Coverage of the 2026 Academy Awards turned into a wider debate about whether Hollywood has leaned too heavily on GLP-1 medications for weight loss, after actors including Demi Moore, Emma Stone, Nicole Kidman, Barbie Ferreira, Kathy Bates and Melissa McCarthy appeared visibly thinner on the red carpet than in past years ^[1][2]. Social media users compared the look to the "heroin chic" aesthetic of the 1990s, with one X post describing some stars as "skin and bones" and a "husk" of their former selves ^[1].

GLP-1 drugs such as Ozempic and Mounjaro were originally approved to treat type 2 diabetes before their weight-loss effects made them popular off-label, including in entertainment circles ^[1][2]. Oprah Winfrey, who has publicly said she uses a GLP-1 medication, also drew comparisons after her appearance at Paris Fashion Week this month, though outlets did not report similar confirmations from the other actors named in Oscars coverage ^[1].

Doctors quoted in coverage said the drugs work by mimicking hormones that regulate blood sugar and appetite, slowing stomach emptying and reducing hunger, which can produce rapid weight loss ^[2]. They also cautioned that off-label, unsupervised use carries risks including nausea, vomiting, diarrhea, constipation and severe abdominal pain, with less common but more serious complications such as pancreatitis and gallbladder disease ^[2]. Some doctors also raised concerns about "Ozempic face," a term for facial volume loss after rapid weight loss, along with muscle loss and nutritional deficiencies when the drugs are used without proper dietary guidance ^[2].

Why it matters for patients

For people using GLP-1 drugs for diabetes or obesity under a doctor's care, the Oscars coverage is mostly a reminder that these medications carry real physical trade-offs even when they work as intended. Reports noted that rising demand tied to weight-loss and cosmetic use has contributed to supply shortages in recent years, a dynamic doctors say could make it harder for patients who need the drugs to manage blood sugar to get their prescriptions filled ^[2].

The coverage also highlights a gap between how these drugs are approved to be used and how they are sometimes discussed in celebrity culture. Public health experts quoted in one report said GLP-1 medications are intended for people with obesity or diabetes who meet specific clinical criteria and should be used under medical supervision, not as a general tool for cosmetic weight loss ^[2]. Neither source cited in this story reported confirmation from most of the actors named that they were using GLP-1 drugs, meaning much of the public discussion rests on appearance and speculation rather than disclosed medical information ^[1][2].

That speculation itself is part of the story. Outlets openly debated whether "skinny was back" in Hollywood after several years of body-positivity messaging in the industry, with one report calling the shift toward thinner frames a sharp contrast to that earlier movement ^[1]. What is not established in the available reporting is how many of the actors discussed, if any, are actually taking a GLP-1 drug, or whether any used it for a diagnosed medical condition versus cosmetic reasons; that detail remains unconfirmed based on the sources reviewed here.

What happens next

The reports reviewed do not include specific dated milestones beyond the Oscars ceremony and the pre-Oscars events already covered, so any further developments — including possible statements from the actors named, or updated supply data — are not yet known from these sources.